Zoetewij J P, van de Water B, de Bont H J, Nagelkerke J F
Division of Toxicology, Leiden-Amsterdam Center for Drug Research, Leiden University, The Netherlands.
Hepatology. 1996 Apr;23(4):858-65. doi: 10.1002/hep.510230429.
Extracellular adenosine triphosphate (ATP o) (0.4 mmol/L), a P2-purinergic receptor agonist, induces cytolysis in several cell types including isolated rat hepatocytes. In this study, we investigated the P2-receptor involved in ATP o-induced, Ca2+-dependent cytotoxicity in hepatocytes. Pretreatment of hepatocytes with oxidized ATP, a P2z-receptor antagonist, or complexation of ATP(4-) (the agonist for the P2z-receptor) with an excess of Mg2+, prevented ATP o-induced cell death. Both protective treatments also prevented the development of a sustained high intracellular Ca2+ concentration as well as the subsequent accumulation of inorganic phosphate (Pi). The P2Z-receptor agonist 3'-O-'(4-benzoylbenzoyl)-ATP (BzATP) was twofold more potent than ATP in eliciting cytolysis, which was preceded by a sustained high intracellular Ca2+ concentration; pretreatment with oxidized ATP prevented both the increase in the intracellular Ca2+ concentration and cell death. Prevention of ATP o-induced cell death, as well as the increases in the intracellular Ca2+ concentration and inorganic phosphate (Pi) was also achieved by decreasing the pH o to 6.9. Together the findings indicate that Ca2+-dependent cell killing by extracellular ATP in hepatocytes is mediated by a P2Z-receptor. The cytolytic effects correlated specifically with a secondary "late" increase in the intracellular Ca2+ concentration.
细胞外三磷酸腺苷(ATPₒ)(0.4 mmol/L),一种P2 - 嘌呤能受体激动剂,可诱导包括分离的大鼠肝细胞在内的多种细胞类型发生细胞溶解。在本研究中,我们调查了参与ATPₒ诱导的肝细胞中钙依赖性细胞毒性的P2受体。用氧化ATP(一种P2z受体拮抗剂)预处理肝细胞,或使ATP⁴⁻(P2z受体激动剂)与过量的Mg²⁺络合,可防止ATPₒ诱导的细胞死亡。这两种保护处理还可防止持续的高细胞内钙浓度的出现以及随后无机磷酸盐(Pi)的积累。P2Z受体激动剂3'-O-(4-苯甲酰苯甲酰基)-ATP(BzATP)在引发细胞溶解方面的效力比ATP高两倍,细胞溶解之前会出现持续的高细胞内钙浓度;用氧化ATP预处理可防止细胞内钙浓度升高和细胞死亡。将细胞外pH降至6.9也可防止ATPₒ诱导的细胞死亡以及细胞内钙浓度和无机磷酸盐(Pi)的升高。这些发现共同表明,肝细胞中细胞外ATP的钙依赖性细胞杀伤是由P2Z受体介导的。细胞溶解作用与细胞内钙浓度的继发性“晚期”升高密切相关。